Our Drug Discovery Alliance has started work on 17 projects exploring potential new dementia treatments – eight of which have already progressed to the next stage. The Alliance unites academic researchers and dedicated drug discovery scientists at the Universities of Cambridge and Oxford, and University College London.

Find out more about the Chief Scientific Officers of our Institutes in London and Oxford, and what makes them tick.

See more achievements.